deltatrials
Unknown NCT00487604

Retrospective Study of the Impact of Drug Eluting Stents

Retrospective Study of the Impact of Drug Eluting Stents on Intermediate Term Survival, Cardiovascular Outcomes Including Revascularization, Bleeding Rates and Economic Costs

Sponsor: Providence Health & Services

Conditions Coronary Artery Disease
Updated 6 times since 2017 Last updated: Aug 1, 2007 Started: May 31, 2007 Completion: May 31, 2008

Listed as NCT00487604, this observational or N/A phase trial focuses on Coronary Artery Disease and remains ongoing. Sponsored by Providence Health & Services, it has been updated 6 times since 2007, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status

  5. Apr 2018 — Jun 2018 [monthly]

    Unknown Status

    Phase: NA → None

▶ Show 1 earlier version

  1. Jan 2017 — Apr 2018 [monthly]

    Unknown Status NA

    First recorded

May 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Providence Health & Services
Data source: Providence Health & Services

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Spokane, United States